MULTICENTER PROBE STUDY-3; COMPARISON OF THE EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000012767
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Department of Medicine and Clinical Sciences,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The patients with 1) severe renal dysfunction (Cr > 2.0 mg/dl) 2) severe hepatic dysfunction (AST or ALT > 100IU/l) 3) the history of severe side effect of ARBs 4) pregnancy or lactation 5) malignancy or other poor-prognosis disease 6) those who are considered inappropriate by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in MCP-1, MDA-LDL, Pentraxin-3, hs-CRP
- Secondary Outcome Measures
Name Time Method Change in the clinic and home blood pressure, renal function(serum creatinine, uric acid, pottasium, eGFR), Lipids(LDL-C, HDL-C, T.cho), U-Alb/Cr